The Leadership Team at Confo Therapeutics is responsible for setting the strategic direction and overseeing the operational execution of the company's drug discovery initiatives. Comprising key executives such as the CEO, CSO, and Chief Counsel, the team focuses on leveraging the innovative CONFO® technology to advance GPCR agonist discovery while ensuring intellectual property protection and regulatory compliance. Their collective expertise guides the company's mission to revolutionize drug development in this complex therapeutic area.
View all